"Insulin, Short-Acting" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Insulin derivatives and preparations that are designed to induce a rapid HYPOGLYCEMIC EFFECT.
| Descriptor ID |
D061266
|
| MeSH Number(s) |
D06.472.699.587.200.400 D12.644.548.586.200.400
|
| Concept/Terms |
Insulin, Short-Acting- Insulin, Short-Acting
- Insulin, Short Acting
- Short-Acting Insulin
- Insulin, Rapid-Acting
- Insulin, Rapid Acting
- Rapid-Acting Insulin
|
Below are MeSH descriptors whose meaning is more general than "Insulin, Short-Acting".
Below are MeSH descriptors whose meaning is more specific than "Insulin, Short-Acting".
This graph shows the total number of publications written about "Insulin, Short-Acting" by people in this website by year, and whether "Insulin, Short-Acting" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2013 | 1 | 0 | 1 |
| 2014 | 2 | 0 | 2 |
| 2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Insulin, Short-Acting" by people in Profiles.
-
Application of Machine Learning to Assess Interindividual Variability in Rapid-Acting Insulin Responses After Subcutaneous Injection in People With Type 1 Diabetes. Can J Diabetes. 2022 Apr; 46(3):225-232.e2.
-
Metabolic implications when employing heavy pre- and post-exercise rapid-acting insulin reductions to prevent hypoglycaemia in type 1 diabetes patients: a randomised clinical trial. PLoS One. 2014; 9(5):e97143.
-
A low-glycemic index meal and bedtime snack prevents postprandial hyperglycemia and associated rises in inflammatory markers, providing protection from early but not late nocturnal hypoglycemia following evening exercise in type 1 diabetes. Diabetes Care. 2014 Jul; 37(7):1845-53.
-
Large pre- and postexercise rapid-acting insulin reductions preserve glycemia and prevent early- but not late-onset hypoglycemia in patients with type 1 diabetes. Diabetes Care. 2013 Aug; 36(8):2217-24.